Navigation Links
Royalty Pharma Announces Proposal To Acquire Elan
Date:2/25/2013

pan>Ireland and the Proposal may be affected by the laws of relevant jurisdictions. Therefore any persons who are subject to the laws of any jurisdiction other than Ireland or Elan Shareholders who are not resident in Ireland will need to inform themselves about, and observe, any applicable requirements.

Additional InformationThis announcement does not constitute an offer to buy or the solicitation of an offer to sell any securities. This announcement relates to a potential business combination transaction with Elan proposed by Royalty Pharma and is not a substitute for any tender offer statement or any other document in the event that Royalty Pharma files such a document with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Any such documents will be available free of charge through the website maintained by the SEC at www.sec.gov or by directing a request to the persons listed above.

General THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE OR EXCHANGE, ANY SECURITIES OR THE SOLICITATION OF ANY VOTE OR APPROVAL IN ANY JURISDICTION.

Responsibility StatementsThe member of RP Management, LLC accepts responsibility for the information contained in this announcement, save that the only responsibility accepted by the member of RP Management, LLC in respect of the information in this announcement relating to Elan, the Elan Group, the Board of Elan and the persons connected with them, which has been compiled from published sources, has been to ensure that such information has been correctly and fairly reproduced or presented (and no steps have been taken by the member
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
3. Health Outcomes Liaisons (HOLs) Serve as Key Bridge between Pharmaceutical Sector and Managed Care Groups
4. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
5. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
7. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
8. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
9. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
10. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) a ... patent-pending technologies poised to redefine how consumers receive energy, medicines, ... business update teleconference and webcast for shareholders and the investment ... PM ET. Fuse Science, Inc. CEO, ... will be joined by Rubin Hanan , ...
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/17/2013)... BEIJING , May 17, 2013 Sinovac Biotech ... vaccines in China , today announced that ... quarter ended March 31, 2013, before market on Tuesday, May ... Tuesday, May 28, 2013, at 8:00 a.m. EDT (May 28, ... Company,s financial results and provide an update on recent corporate ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3
... to be Dosed Shortly -, SAN DIEGO, March ... completion of the safety and,tolerability assessment of its third ... new HspE7 (HspE7 + Poly-ICLC) in patients with cervical,intraepithelial ... and met the limits prescribed in the trial protocol, ...
... will remain open until March 21, 2008, ... as,government agencies when implementing new policies, a national ... today,called for public comment on a series of ... trials., As part of the four year ...
Cached Medicine Technology:Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial 5EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations 2
(Date:5/18/2013)... Pomona, NY (PRWEB) May 18, 2013 Dr. ... sleep apnea dentistry, employs his knowledge of the ... in sleep apnea patients. With May being Better Sleep Month, ... have some sort of chronic sleep disorder, and sleep apnea ... With sleep apnea, a person will essentially stop breathing at ...
(Date:5/18/2013)... May 18, 2013 John Ravera, D.D.S., a ... addition of a new member to his dental team, Courtney ... in the field for over 10 years. She received her ... and was elected a member of Sigma Pi Alpha, a ... Marino enjoys working with patients of all ages, helping them ...
(Date:5/18/2013)... 2013 According to the the Stevens Johnson ... Epidermal Necrolysis, is a severe allergic reaction usually to medicine ... but it can quickly advance causing blistering and large areas ... death. SJS can develop at any time and seriously ... NBA player, Manute Bol, passed away after he received kidney ...
(Date:5/18/2013)... The product liability attorneys at Wright & Schulte have ... nationwide who have sustained serious tendon injuries allegedly caused by ... all part of MDL 2308 and were all filed on ... heard in the U.S. District Court of the Western District ... specializes in defending the rights of those who have suffered ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Daily Gossip announced ... with the creator of the Program Yourself Thin ... on their online website by the end of the month ... accomplish to successfully reeducate themselves and lead a healthy lifestyle, ... Program Yourself Thin package is available for only $97 ...
Breaking Medicine News(10 mins):Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:Program Yourself Thin Review and Secrets Revealed By Daily Gossip Magazine 2
... its key inflammatory mediators (IL-12 and IL-23) is highly ... researchers. ,Current treatments for psoriasis include ... symptoms of the disease. Many of these treatments are ... very effective, according to Gerald Krueger, M.D., principal investigator ...
... extreme losses -- in two cases, greater than $100,000 -- ... been linked to a class of drugs commonly used to ... Mayo Clinic study is the first to describe this compulsive ... that stimulate dopamine receptors in the brain. ,The ...
... A botched up family planning operation would have claimed one ... of Indian origin// wasn't there to perform a lifesaving surgery. ... 300 km from here, was a boon for Vijayanti Devi, ... was cut out by mistake during a routine family planning ...
... set to start its manufacturing facility in the ... drug market. ,Ind-Swift Laboratories has completed ... its Clarithromycin active pharmaceutical ingredient (API) manufacturing unit, ... ,Clarithromycin is a macrolide antibiotic molecule ...
... diagnosis laboratories and counselling centres in various hospitals as HIV ... ,The decision was announced at the second meeting of the ... UNB reported. ,The meeting, chaired by health advisor ... policy, said a press release. ,The meeting decided ...
... of diseases or disorders of the valves in the heart ... caused by diseases such as rheumatic fever, or degenerative// conditions ... for valvular heart disease (VHD) highlight the need for improvement ... chair of the European Society of Cardiology (ESC) task force ...
Cached Medicine News:Health News:New Treatment For Psoriasis Is Highly Effective 2Health News:Medications for Restless Legs Syndrome may Trigger Compulsive Gambling 2Health News:Medications for Restless Legs Syndrome may Trigger Compulsive Gambling 3Health News:New Guidelines for VHD 2Health News:New Guidelines for VHD 3Health News:New Guidelines for VHD 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: